Medical Condition News

RSS

Covidien analysis finds lower incidence of GI adverse events with topical NSAIDs versus oral

Covidien, a leading global provider of healthcare products, announced the results of an analysis that will be presented at the American College of Rheumatology's Annual Scientific Meeting. A pooled analysis of safety data suggests that patients with knee osteoarthritis (OA) receiving the topical PENNSAID® (diclofenac sodium topical solution) 1.5% w/w had significantly fewer gastrointestinal (GI)-related adverse events than those receiving an oral non-steroidal anti-inflammatory drug (NSAID).

10 Nov 2010

Data from AVEO's tivozanib-FOLFOX6 combination Phase 1b trial presented at 22nd EORTC-NCI-AACR

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, will be presented during the 22nd Annual Symposium of EORTC-NCI-AACR being held November 16-19, 2010 in Berlin, Germany.

10 Nov 2010

TRU-016 abstracts to be presented at ASH meeting

Emergent BioSolutions Inc. today announced the acceptance of four abstracts for presentation at the 52nd Annual Meeting of the American Society of Hematology to be held from December 4 to 7 in Orlando, Florida. The presentations include an oral presentation on the results of a Phase I dose escalation, monotherapy study of TRU-016 for patients with chronic lymphocytic leukemia.

10 Nov 2010

Nuffield Health Leeds Hospital offers incisionless TOGA Procedure for treatment of obesity

Nuffield Health Leeds Hospital announced today that it will be the first hospital in the UK to offer the incisionless TOGA® Procedure for treatment of obesity commencing in January 2011. The TOGA Procedure has been used to treat over 450 patients worldwide - its incision-free approach is very minimally invasive and offers the benefits of minimal pain and downtime, and an excellent safety profile.

10 Nov 2010

Low levels of growth hormone may contribute to growth defects in cystic fibrosis

A new study using a pig model of cystic fibrosis (CF) suggests that low levels of a growth promoting hormone at or before birth may contribute to growth defects in patients with CF.

10 Nov 2010

Long-term use of statins unlikely to substantially increase overall cancer risk: Study

Researchers have further established that long-term use of statins is unlikely to substantially increase or decrease overall cancer risk, according to study results presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held Nov. 7-10, 2010, in Philadelphia.

10 Nov 2010

Myrexis presents key preclinical findings of MPI-0485520 at ACR/ARHP meeting

Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today presented key preclinical findings of the Company's novel oral anti-interferon, MPI-0485520, at the 74th Annual Scientific Meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals, in Atlanta, Georgia.

10 Nov 2010

Psychologists find stress is taking physical and emotional health toll on family and children

Findings from the American Psychological Association's (APA) newly released 2010 Stress in America survey raise red flags about the long-term impact that chronic stress could have on our physical and emotional health and the health of our families, psychologists said today.

10 Nov 2010

Jefferson awarded $2.6M grant for study on cognitive decline in older African Americans with MCI

Researchers in the Departments of Psychiatry and Neurology at Jefferson Medical College of Thomas Jefferson University were recently awarded a $2.6 million grant from The National Institute of Health to study whether increasing participation in cognitive, physical and/or social activities prevents cognitive decline in older African Americans with Mild Cognitive Impairment (MCI).

10 Nov 2010

Researchers study drug's ability to restore retinal health in eyes of diabetic patients

One drug's startling ability to restore retinal health in the eyes of diabetic mice has researchers wanting to learn more about how it works and whether it might do the same for people.

10 Nov 2010

Epratuzumab reduces SLE disease activity in phase IIB EMBLEM study

UCB and U.S. based partner Immunomedics Inc. announced that results from the phase IIB study, EMBLEM, showed that certain doses of epratuzumab were associated with a meaningful and statistically significant reduction in disease activity in adult patients with moderate to severe active SLE.

10 Nov 2010

Experts to discuss public health issues on using mobile health technology at 2010 mHealth Summit

As obesity rates and the cost of healthcare continue to be on the rise, the 2010 mHealth Summit in Washington D.C. is bringing together industry thought leaders, researchers, and policy makers to discuss the opportunities to address pressing public health issues utilizing mobile health technology.

10 Nov 2010

Researcher awarded Sylvia and Charles Viertel Charitable Foundation Fellowship

Walter and Eliza Hall Institute researcher Dr Ross Dickins has been awarded a Sylvia and Charles Viertel Charitable Foundation Fellowship worth $AUD975,000 over five years.

10 Nov 2010

Researchers to determine levels of stroke risk in patients with narrowed brain arteries

Neurological researchers at Rush University Medical Center are part of a multicenter, National Institutes of Health (NIH) study to determine the levels of stroke risk and stroke recurrence in patients with narrowed brain arteries.

10 Nov 2010

18 partner consortium to develop lab-on-a-chip to detect brain diseases

A consortium of 18 partners embarks on the development of a lab-on-a-chip to detect Alzheimer´s disease and similar diseases in the brain. The project is funded by the EU´s 7th Framework programme for nanotechnology.

10 Nov 2010

NEWMEDS launches largest database to advance drug development for depressio, schizophrenia

In a remarkable and unprecedented collaboration NEWMEDS (Novel Methods leading to NeW MEdications in Depression and Schizophrenia) have pooled resources to bring together data of 23,401 anonymized patients from 67 trials on 11 compounds in over 25 countries to form the single largest database of clinical trial data ever amassed in psychiatric research.

10 Nov 2010

Study sheds light on difficulty of controlling blood pressure in patients with high aldosterone levels

A hormone already responsible for increasing blood pressure by prompting the kidneys to retain salt appears to moonlight as a major stimulator of the brain centers that control the vascular system and blood pressure.

10 Nov 2010

UC Davis researchers identify new pathway to repair oxidative-damaged DNA

UC Davis researchers have found a new pathway for repairing DNA damaged by oxygen radicals. The results are published this week in the journal Proceedings of the National Academy of Sciences.

10 Nov 2010

Depression in nursing home residents often unrecognized

Depression affects approximately 30 to 40 percent of nursing home residents, but it often goes unrecognized, according to American Geriatrics Society, which can lead to lower quality of life or even suicide. Now, researchers at the University of Missouri have found a series of indicators, other than changes in mood that are associated with the development of depression in nursing home residents.

10 Nov 2010

Experts develop new screening test to detect dementia in elderly patients

Dementia and cognitive impairment are widespread among elderly individuals in the United States, affecting more than 8 million people to some degree.

10 Nov 2010

Medical Condition News

Covidien analysis finds lower incidence of GI adverse events with topical NSAIDs versus oral

Data from AVEO's tivozanib-FOLFOX6 combination Phase 1b trial presented at 22nd EORTC-NCI-AACR

TRU-016 abstracts to be presented at ASH meeting

Nuffield Health Leeds Hospital offers incisionless TOGA Procedure for treatment of obesity

Low levels of growth hormone may contribute to growth defects in cystic fibrosis

Long-term use of statins unlikely to substantially increase overall cancer risk: Study

Myrexis presents key preclinical findings of MPI-0485520 at ACR/ARHP meeting

Psychologists find stress is taking physical and emotional health toll on family and children

Jefferson awarded $2.6M grant for study on cognitive decline in older African Americans with MCI

Researchers study drug's ability to restore retinal health in eyes of diabetic patients

Epratuzumab reduces SLE disease activity in phase IIB EMBLEM study

Experts to discuss public health issues on using mobile health technology at 2010 mHealth Summit

Researcher awarded Sylvia and Charles Viertel Charitable Foundation Fellowship

Researchers to determine levels of stroke risk in patients with narrowed brain arteries

18 partner consortium to develop lab-on-a-chip to detect brain diseases

NEWMEDS launches largest database to advance drug development for depressio, schizophrenia

Study sheds light on difficulty of controlling blood pressure in patients with high aldosterone levels

UC Davis researchers identify new pathway to repair oxidative-damaged DNA

Depression in nursing home residents often unrecognized

Experts develop new screening test to detect dementia in elderly patients

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Latest News